X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
melanoma (34) 34
index medicus (32) 32
oncology (29) 29
humans (23) 23
immunotherapy (21) 21
ipilimumab (17) 17
cancer (16) 16
metastasis (16) 16
survival (15) 15
middle aged (14) 14
article (13) 13
male (13) 13
female (12) 12
open-label (12) 12
metastases (11) 11
adult (10) 10
care and treatment (10) 10
brain metastases (9) 9
dermatology (9) 9
aged (8) 8
melanoma - drug therapy (8) 8
metastatic melanoma (8) 8
toxicity (8) 8
abridged index medicus (7) 7
brain neoplasms - secondary (7) 7
melanoma - pathology (7) 7
patients (7) 7
stereotactic radiosurgery (7) 7
tumors (7) 7
analysis (6) 6
cell lung-cancer (6) 6
expression (6) 6
immune checkpoint (6) 6
melanoma - therapy (6) 6
mutation (6) 6
nivolumab (6) 6
surgery (6) 6
targeted therapy (6) 6
brain (5) 5
cell biology (5) 5
clinical neurology (5) 5
clinical trials (5) 5
ctla-4 blockade (5) 5
leptomeningeal disease (5) 5
medicine, research & experimental (5) 5
melanoma - secondary (5) 5
multicenter (5) 5
pathology (5) 5
pembrolizumab (5) 5
radiation (5) 5
radiation necrosis (5) 5
risk groups (5) 5
therapy (5) 5
young adult (5) 5
antineoplastic agents, immunological - therapeutic use (4) 4
biopsy (4) 4
brain metastasis (4) 4
brain neoplasms - therapy (4) 4
breast cancer (4) 4
breast-cancer (4) 4
cancer therapies (4) 4
central nervous system (4) 4
chemotherapy (4) 4
combined nivolumab (4) 4
ctla-4 antigen - antagonists & inhibitors (4) 4
diagnosis (4) 4
drug resistance, neoplasm (4) 4
medicine & public health (4) 4
melanoma - immunology (4) 4
phase-2 trial (4) 4
programmed cell death 1 receptor - antagonists & inhibitors (4) 4
radiosurgery (4) 4
tumor-infiltrating lymphocytes (4) 4
acquired-resistance (3) 3
advanced melanoma (3) 3
aged, 80 and over (3) 3
anti-pd-1 (3) 3
biomarkers (3) 3
biomarkers, tumor - genetics (3) 3
brain neoplasms - drug therapy (3) 3
chemical and pharmacologic phenomena (3) 3
corticosteroids (3) 3
ctla-4 (3) 3
dabrafenib (3) 3
disease progression (3) 3
disease-free survival (3) 3
immunohistochemistry (3) 3
immunology (3) 3
immunotherapy - methods (3) 3
inhibition (3) 3
ipilimumab - therapeutic use (3) 3
leptomeningeal metastases (3) 3
malignant-melanoma (3) 3
medical prognosis (3) 3
melanoma - metabolism (3) 3
meninges (3) 3
methods (3) 3
multiple myeloma (3) 3
mutation - genetics (3) 3
neoplasms (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 9, pp. 858 - 858
Journal Article
Advances in experimental medicine and biology, ISSN 0065-2598, 2018, Volume 995, pp. 43 - 63
While melanoma is less common than some other skin cancers, it is responsible for nearly 10,000 deaths in the USA each year alone. For many decades, very... 
Pembrolizumab | Brain metastasis | Immunotherapy | Ipilimumab | Nivolumab | Melanoma | PD-L1 | CTLA-4 | PD-1 | Adjuvant therapy
Journal Article
Annals of Oncology, ISSN 0923-7534, 07/2018, Volume 29, Issue 7, pp. 1509 - 1520
Journal Article
JOURNAL OF NEURO-ONCOLOGY, ISSN 0167-594X, 05/2019, Volume 142, Issue 3, pp. 499 - 509
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 1714 - 1714
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 3601 - 3601
Journal Article
Therapeutic Advances in Medical Oncology, ISSN 1758-8340, 05/2019, Volume 11, p. 1758835919851663
In recent years, several drugs have been approved for the treatment of patients with metastatic cutaneous melanoma, completely reshaping the landscape of this... 
targeted therapy | metastatic brain tumors | immunotherapy | BRAF inhibitor | combination immunotherapy | melanoma | anti-PD-1 | treatment sequencing | MUTATION-POSITIVE MELANOMA | PHASE-III | COMBINED NIVOLUMAB | OPEN-LABEL | CEREBRAL METASTASES | TUMOR-INFILTRATING LYMPHOCYTES | STEREOTACTIC RADIOSURGERY | ADOPTIVE TRANSFER | ONCOLOGY | BRAIN METASTASES | HIGH-DOSE INTERLEUKIN-2
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 4989 - 4989
Abstract Abstract 4989 Background: The proto-oncogene c-MYC encodes a transcription factor that regulates cell proliferation, growth, and apoptosis. c-MYC is... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 5090 - 5090
Abstract Abstract 5090 Background: The proto-oncogene c-MYC encodes a transcription factor that regulates cell proliferation, growth, and apoptosis. c-MYC is... 
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. CT332 - CT332
Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue S11, pp. 2163 - 2175
Substantial proportions of patients with metastatic melanoma develop brain metastases during the course of their disease, often resulting in significant... 
immunotherapies | targeted therapies | blood‐brain barrier | immune cells | melanoma | brain metastasis | brain parenchyma | blood-brain barrier | COMBINATION THERAPY | OPEN-LABEL | MALIGNANT-MELANOMA | TUMOR-INFILTRATING LYMPHOCYTES | BREAST-CANCER CELLS | STEREOTACTIC RADIOSURGERY | ONCOLOGY | THERAPEUTIC TARGETS | CENTRAL-NERVOUS-SYSTEM | ENDOTHELIAL GROWTH-FACTOR | PHASE-2 TRIAL | Tumor Escape | Transforming Growth Factor beta2 - metabolism | Humans | Glucuronidase - metabolism | Radiosurgery | Extracellular Matrix - metabolism | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - metabolism | Molecular Targeted Therapy | Integrins - metabolism | Brain Neoplasms - metabolism | Receptors, CCR4 - metabolism | Brain Neoplasms - secondary | Immunotherapy | Fibroblast Growth Factor 2 - metabolism | Melanoma - metabolism | Skin Neoplasms - pathology | Cytokines - metabolism | B7-H1 Antigen | Matrix Metalloproteinase 2 - metabolism | Cranial Irradiation | Cell Adhesion | Melanoma - secondary | Skin Neoplasms - metabolism | Brain Neoplasms - therapy | Neovascularization, Pathologic - metabolism | Melanoma - therapy | Blood-Brain Barrier | Medical research | Brain | Therapy | Toxicity | Melanoma | Clinical trials | Pharmacology | Metastasis | Drug development | Chemical compounds | Patients | Morbidity | Metastases | Immune checkpoint | Design improvements | Platinum | Cancer
Journal Article
Cancer Discovery, ISSN 2159-8274, 02/2016, Volume 6, Issue 2, pp. 202 - 216
Journal Article
Cancer Research, ISSN 0008-5472, 09/2018, Volume 78, Issue 18, pp. 5249 - 5262
Systemic metastasis is the major cause of death from melanoma, the most lethal form of skin cancer. Although most patients with melanoma exhibit a substantial... 
MIGRATION | SURVIVAL | HETEROGENEITY | INVASION | INHIBITION | CIRCULATING TUMOR-CELLS | ONCOLOGY | PREDICT | DISSEMINATION | EXPRESSION | PROGRESSION | USP7 | circulating tumor cells | metastasis | bone marrow | Melanoma
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.